BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16699859)

  • 1. Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy.
    Nanashima A; Sumida Y; Abo T; Shindou H; Fukuoka H; Takeshita H; Hidaka S; Tanaka K; Sawai T; Yasutake T; Nagayasu T; Omagari K; Mine M
    J Gastroenterol; 2006 Mar; 41(3):250-6. PubMed ID: 16699859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.
    Nanashima A; Omagari K; Tobinaga S; Shibata K; Sumida Y; Mine M; Morino S; Shibasaki S; Ide N; Shindou H; Nagayasu T
    Eur J Surg Oncol; 2005 Oct; 31(8):882-90. PubMed ID: 15993031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
    Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
    J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified CLIP using PIVKA-II for evaluating prognosis after hepatectomy for hepatocellular carcinoma.
    Nanashima A; Morino S; Yamaguchi H; Tanaka K; Shibasaki S; Tsuji T; Hidaka S; Sawai T; Yasutake T; Nakagoe T
    Eur J Surg Oncol; 2003 Nov; 29(9):735-42. PubMed ID: 14602492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
    Kudo M; Chung H; Osaki Y
    J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of three staging systems for hepatocellular carcinoma (JIS score, biomarker-combined JIS score and BCLC system) in 4,649 cases from a Japanese nationwide survey.
    Kitai S; Kudo M; Izumi N; Kaneko S; Ku Y; Kokudo N; Sakamoto M; Takayama T; Nakashima O; Kadoya M; Matsuyama Y; Matsunaga T
    Dig Dis; 2014; 32(6):717-24. PubMed ID: 25376289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients.
    Yen YH; Changchien CS; Wang JH; Kee KM; Hung CH; Hu TH; Lee CM; Lin CY; Wang CC; Chen TY; Huang YJ; Lu SN
    Dig Liver Dis; 2009 Jun; 41(6):431-41. PubMed ID: 19185555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new classification for hepatocellular carcinoma with portal vein tumor thrombus.
    Shi J; Lai EC; Li N; Guo WX; Xue J; Lau WY; Wu MC; Cheng SQ
    J Hepatobiliary Pancreat Sci; 2011 Jan; 18(1):74-80. PubMed ID: 20686792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the Japan Integrated Stage (JIS) and modified JIS score as a predictor of survival after hepatectomy for hepatocellular carcinoma.
    Luo KZ; Itamoto T; Amano H; Oshita A; Ushitora Y; Tanimoto Y; Ohdan H; Tashiro H; Asahara T
    J Gastroenterol; 2008; 43(5):369-77. PubMed ID: 18592155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Japanese integrated staging score using liver damage grade for hepatocellular carcinoma in patients after hepatectomy.
    Nanashima A; Sumida Y; Morino S; Yamaguchi H; Tanaka K; Shibasaki S; Ide N; Sawai T; Yasutake T; Nakagoe T; Nagayasu T
    Eur J Surg Oncol; 2004 Sep; 30(7):765-70. PubMed ID: 15296991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma.
    Takada H; Amemiya F; Yasumura T; Yoda H; Okuwaki T; Imagawa N; Shimamura N; Tanaka K; Kadokura M; Maekawa S; Enomoto N
    Sci Rep; 2020 Jun; 10(1):10186. PubMed ID: 32576956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of seven prognostic staging systems in patients who undergo hepatectomy for hepatocellular carcinoma.
    Kondo K; Chijiiwa K; Nagano M; Hiyoshi M; Kai M; Maehara N; Ohuchida J; Nakao H; Ohkuwa Y
    Hepatogastroenterology; 2007; 54(77):1534-8. PubMed ID: 17708292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.
    Kudo M; Chung H; Haji S; Osaki Y; Oka H; Seki T; Kasugai H; Sasaki Y; Matsunaga T
    Hepatology; 2004 Dec; 40(6):1396-405. PubMed ID: 15565571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy.
    Chen TW; Chu CM; Yu JC; Chen CJ; Chan DC; Liu YC; Hsieh CB
    Eur J Surg Oncol; 2007 May; 33(4):480-7. PubMed ID: 17129701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor marker levels before and after curative treatment of hepatocellular carcinoma as predictors of patient survival.
    Nanashima A; Taura N; Abo T; Ichikawa T; Sakamoto I; Nagayasu T; Nakao K
    Dig Dis Sci; 2011 Oct; 56(10):3086-100. PubMed ID: 21706206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which system is better to predict prognosis of patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization as initial therapy? Comparison between CLIP and JIS in a Japanese population.
    Urakawa H; Kora SI; Mitsufuji T; Osame A; Higahsihara H; Yoshimitsu K
    Acta Radiol; 2016 Dec; 57(12):1445-1452. PubMed ID: 26861204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposal of the performance status combined Japan Integrated Staging system in hepatocellular carcinoma complicated with cirrhosis.
    Nishikawa H; Kita R; Kimura T; Endo M; Ohara Y; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Osaki Y
    Int J Oncol; 2015; 46(6):2371-9. PubMed ID: 25891119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
    Hiraoka A; Kumada T; Michitaka K; Toyoda H; Tada T; Ueki H; Kaneto M; Aibiki T; Okudaira T; Kawakami T; Kawamura T; Yamago H; Suga Y; Miyamoto Y; Tomida H; Azemoto N; Mori K; Miyata H; Ninomiya T; Kawasaki H
    J Gastroenterol Hepatol; 2016 May; 31(5):1031-6. PubMed ID: 26647219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the best staging system for hepatocellular carcinoma?
    Kudo M
    J Gastroenterol; 2006 Mar; 41(3):290-1. PubMed ID: 16699867
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.